Ultrasonographic Characterization of Parametrial Lesions in Deep Endometriosis: A Diagnostic-Accuracy Study (ULTRA-PARAMETRENDO III)

Sponsor
IRCCS Sacro Cuore Don Calabria di Negrar (Other)
Overall Status
Recruiting
CT.gov ID
NCT06017531
Collaborator
(none)
600
1
5.2
116.3

Study Details

Study Description

Brief Summary

This is a single-center, prospective diagnostic-accuracy study. All women who will undergo surgery for DE after preoperative ultrasound for six consecutive months will be included. Anamnestic and preoperative (physical objective and ultrasonographic) data of these patients will be collected. Surgical and pathological data will be analyzed to confirm the presence of parametrial DE.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    This is a single-center, prospective diagnostic-accuracy study. All women who will undergo surgery for DE after preoperative ultrasound for six consecutive months will be included. Anamnestic and preoperative (physical objective and ultrasonographic) data of these patients will be collected. Surgical and pathological data will be analyzed to confirm the presence of parametrial DE.

    All the study procedures are done according to our clinical practice. Demographic and ultrasonographic data will be collected from the preoperative evaluation, which is routinely done at our institution by four ultrasonographic expert in diagnosing deep endometriosis. Surgical and pathological data will be collected during surgical procedures and hospital stay.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    600 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Ultrasonographic Characterization of Parametrial Lesions in Deep Endometriosis: A Diagnostic-Accuracy Study (ULTRA-PARAMETRENDO III)
    Actual Study Start Date :
    Mar 28, 2023
    Anticipated Primary Completion Date :
    Sep 1, 2023
    Anticipated Study Completion Date :
    Sep 1, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Diagnostic accuracy [Preoperative exam, surgical and/or histological confirmation]

      Diagnostic accuracy of transvaginal ultrasound for detecting the intraoperative presence of parametrial DE with surgical and/or histological confirmation.

    2. Sensitivity [Preoperative exam, surgical and/or histological confirmation]

      Sensitivity of transvaginal ultrasound for detecting the intraoperative presence of parametrial DE with surgical and/or histological confirmation.

    3. Specificity [Preoperative exam, surgical and/or histological confirmation]

      Specificity of transvaginal ultrasound for detecting the intraoperative presence of parametrial DE with surgical and/or histological confirmation.

    4. positive predictive value [Preoperative exam, surgical and/or histological confirmation]

      of transvaginal ultrasound for detecting the intraoperative presence of parametrial DE with surgical and/or histological confirmation.

    5. negative predictive value [Preoperative exam, surgical and/or histological confirmation]

      of transvaginal ultrasound for detecting the intraoperative presence of parametrial DE with surgical and/or histological confirmation.

    6. Positive likelihood ratio [Preoperative exam, surgical and/or histological confirmation]

      Positive likelihood ratio of transvaginal ultrasound for detecting the intraoperative presence of parametrial DE with surgical and/or histological confirmation.

    7. Negative likelihood ratio [Preoperative exam, surgical and/or histological confirmation]

      Negative likelihood ratio of transvaginal ultrasound for detecting the intraoperative presence of parametrial DE with surgical and/or histological confirmation.

    Secondary Outcome Measures

    1. Characteristics of parametrial DE [Preoperative exam]

      Characteristics of parametrial DE (parametrial localizations, size, margins, echogenicity) evaluated at preoperative ultrasound

    2. Parametrial DE in the three different parametrial areas (posterior, lateral, and anterior parametrium) [Preoperative exam, surgical and/or histological confirmation]

      Diagnostic accuracy, sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio, and negative likelihood ratio of transvaginal ultrasound for distinguishing the intraoperative presence of parametrial DE in the three different parametrial areas (posterior, lateral, and anterior parametrium) with surgical and/or histological confirmation.

    3. Infiltration of parametrial DE nodules [Preoperative exam, surgical and/or histological confirmation]

      Diagnostic accuracy, sensitivity, specificity, positive predictive value, negative predictive value, positive likelihood ratio, and negative likelihood ratio of transvaginal ultrasound for detecting the intraoperative infiltration of parametrial DE nodules in other pelvic structures (i.e. rectosigmoid, uterosacral ligaments) with surgical and/or histological confirmation

    4. Other DE nodules and indirect DE signs [Preoperative exam]

      Prevalence of other DE nodules and indirect DE signs in patients in the case of evidence of parametrial DE at preoperative ultrasound

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • clinical suspicion of DE, for which a preoperative transvaginal ultrasonographic assessment and laparoscopic surgical approach will be indicated;

    • age > or equal to 18 years

    • informed consent for the participation in the study and for personal data treatment.

    Exclusion Criteria:
    • previous surgical diagnosis of parametrial DE;

    • previous radiological diagnosis of parametrial DE including techniques used to diagnose DE (such as magnetic resonance [MRI], computed tomography-based virtual colonoscopy [CTC] or double-contrast barium enema);

    • previous bilateral ovariectomy.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 IRCCS Sacro Cuore Don Calabria di Negrar Negrar Verona Italy

    Sponsors and Collaborators

    • IRCCS Sacro Cuore Don Calabria di Negrar

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    IRCCS Sacro Cuore Don Calabria di Negrar
    ClinicalTrials.gov Identifier:
    NCT06017531
    Other Study ID Numbers:
    • 2023-A
    First Posted:
    Aug 30, 2023
    Last Update Posted:
    Aug 30, 2023
    Last Verified:
    Aug 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Aug 30, 2023